FierceBiotech17h
Third Rock-backed Trace uses $101M series A to go after same ALS target as Lilly
Almost all cases of ALS and half of frontotemporal dementia (FTD) cases are linked to dysfunction in a protein TDP-43.
Medical Xpress on MSN12d
Study identifies 51 amyotrophic lateral sclerosis-associated mutations that could help diagnose the disease
Using sequencing techniques, researchers associated 51 mutations in mitochondrial DNA with amyotrophic lateral sclerosis (ALS ...
STAT1d
Fueled by a ‘fall off your chair’ discovery and $101 million, Trace launches to take on ALS
A surprise finding by two independent research teams and a venture capital mega-round have birthed a biotech looking to treat ...
Taiwan News8d
Amyotrophic Lateral Sclerosis (ALS) Market Outlook, Size, Trends, and Growth Opportunities by Type, Treatment, End User, and Region, 2024-2032
Report Ocean, a leading strategic consulting, and Market research firm, in its recent study, estimated Global Amayotrophic Lateral Sclerosis (ALS) Market size by value at USD 902 million in 2023.
Natasha Alexenko, Who Helped Cut Backlog in Rape-Kit Testing, Dies at 51
Ten years after her sexual assault, she discovered that the evidence in her rape kit hadn’t been tested — and neither had ...
Yahoo Finance15h
FDA clears Novavax to resume trials of Covid-19 and flu combo vaccine
The FDA initially halted the trials on 16 October after a patient in the Phase II trial (NCT05519839) of the CIC vaccine ...
Medical Xpress13d
Study identifies 51 amyotrophic lateral sclerosis-associated mutations that could help diagnose the disease
Citation: Study identifies 51 amyotrophic lateral sclerosis-associated mutations that could help diagnose the disease (2024, October 31) retrieved 8 November 2024 from https://medicalxpress.com ...
ProMIS Neurosciences to Participate in Guggenheim’s Inaugural Healthcare Innovation Conference
CAMBRIDGE, Massachusetts and TORONTO, Ontario, Nov. 12, 2024 (GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc. (Nasdaq: PMN), a clinical-stage ...